147 related articles for article (PubMed ID: 29221191)
1. Recommended oral sodium bicarbonate administration for urine alkalinization did not affect the concentration of mitomycin-C in non-muscle invasive bladder cancer patients.
Seo HK; Kim SH; Ahn KO; Lee SJ; Park WS; Kim S; Hwang SH; Lee DH; Joung JY; Chung J; Joo J; Jeong KC
Oncotarget; 2017 Nov; 8(56):96117-96125. PubMed ID: 29221191
[TBL] [Abstract][Full Text] [Related]
2. Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study.
Ersoy H; Yaytokgil M; Karakoyunlu AN; Topaloglu H; Sagnak L; Ozok HU
Drug Des Devel Ther; 2013; 7():1-6. PubMed ID: 23300343
[TBL] [Abstract][Full Text] [Related]
3. Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trial.
Miyata Y; Tsurusaki T; Hayashida Y; Imasato Y; Takehara K; Aoki D; Nishikido M; Watanabe J; Mitsunari K; Matsuo T; Ohba K; Taniguchi K; Sakai H;
BJU Int; 2022 Apr; 129(4):534-541. PubMed ID: 34383381
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of the optimization of the conditions of mitomycin C intravesical instillation completion in the setting of non-muscle invasive bladder cancer treatment].
Lailler G; Neuzillet Y; Rouanne M; Lebret T
Prog Urol; 2016 Feb; 26(2):79-82. PubMed ID: 26653577
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.
Dalton JT; Wientjes MG; Badalament RA; Drago JR; Au JL
Cancer Res; 1991 Oct; 51(19):5144-52. PubMed ID: 1913640
[TBL] [Abstract][Full Text] [Related]
6. Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer.
Racioppi M; Di Gianfrancesco L; Ragonese M; Palermo G; Sacco E; Bassi P
Eur Urol Oncol; 2019 Sep; 2(5):576-583. PubMed ID: 31411974
[TBL] [Abstract][Full Text] [Related]
7. The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
Onishi T; Sekito S; Shibahara T; Uchida K; Sasaki T
Scand J Urol; 2018; 52(5-6):385-388. PubMed ID: 30628540
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder].
Isbarn H; Budäus L; Pichlmeier U; Conrad S; Huland H; Friedrich MG
Urologe A; 2008 May; 47(5):608-15. PubMed ID: 18317718
[TBL] [Abstract][Full Text] [Related]
10. Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
Bosschieter J; Nieuwenhuijzen JA; van Ginkel T; Vis AN; Witte B; Newling D; Beckers GMA; van Moorselaar RJA
Eur Urol; 2018 Feb; 73(2):226-232. PubMed ID: 28705539
[TBL] [Abstract][Full Text] [Related]
11. Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue.
van Valenberg FJP; van der Heijden AG; Lammers RJM; Falke J; Arends TJH; Oosterwijk E; Witjes JA
Int J Hyperthermia; 2018 Nov; 34(7):988-993. PubMed ID: 29191126
[TBL] [Abstract][Full Text] [Related]
12. Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor.
Maeda T; Kikuchi E; Matsumoto K; Miyajima A; Oya M
J Urol; 2011 Mar; 185(3):802-6. PubMed ID: 21239010
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C for the treatment of bladder cancer.
Volpe A; Racioppi M; D'Agostino D; Cappa E; Filianoti A; Bassi PF
Minerva Urol Nefrol; 2010 Jun; 62(2):133-44. PubMed ID: 20562793
[TBL] [Abstract][Full Text] [Related]
14. An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non-muscle-invasive bladder cancer irrespective of prognostic risk groups.
Bosschieter J; Nieuwenhuijzen JA; Vis AN; van Ginkel T; Lissenberg-Witte BI; Beckers GMA; van Moorselaar RJA
Urol Oncol; 2018 Sep; 36(9):400.e7-400.e14. PubMed ID: 30064935
[TBL] [Abstract][Full Text] [Related]
15. Intravesical mitomycin C efficacy in acidic and alkaline urinary pH: impact on recurrence-free survival rate after TURBT.
Naeem MT; Usman AH; Ali S; Raza H; Shah AN; Mahmmoud Fadelallah Eljack M
Ann Med Surg (Lond); 2023 Nov; 85(11):5323-5327. PubMed ID: 37915689
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
[TBL] [Abstract][Full Text] [Related]
17. [Intravesical therapy with mitomycin through electromotive drug administration].
Verri C; Liberati E; Celestino F; De Carlo F; Torelli F; Di Stasi SM
Urologia; 2013; 80(2):105-11. PubMed ID: 23852927
[TBL] [Abstract][Full Text] [Related]
18. Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non-muscle-invasive Bladder Cancer.
Hentschel AE; Blankvoort CJ; Bosschieter J; Vis AN; van Moorselaar RJA; Bosmans JE; Nieuwenhuijzen JA
Eur Urol Open Sci; 2022 Mar; 37():7-13. PubMed ID: 35243387
[TBL] [Abstract][Full Text] [Related]
19. Long-term experience with early single mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial.
De Nunzio C; Carbone A; Albisinni S; Alpi G; Cantiani A; Liberti M; Tubaro A; Iori F
World J Urol; 2011 Aug; 29(4):517-21. PubMed ID: 21594708
[TBL] [Abstract][Full Text] [Related]
20. Behavior and resorption of mitomycin C following multiple intravesical administrations.
van Helsdingen PJ; de Bruijn EA; Sleeboom HP; Rikken CH; Tjaden UR
J Pharm Sci; 1988 Oct; 77(10):843-6. PubMed ID: 3148709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
